Hormone Therapy for Early-Stage Breast Cancer
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
Recruiting
Phase 2
Interventional Study
Breast Cancer Stage I
Breast Cancer Stage II
Breast Cancer Stage III
Carcinoma, Breast
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 21 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 90 (estimated)
- Sponsor
- George Washington University · Other
Who this trial is looking for
This trial is looking for women with early-stage breast cancer who are planning to have surgery. If you join, you will receive hormone therapy and allow researchers to take some samples from your blood and tissue to study how the treatment affects your cancer.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with breast cancer stages I to III.
- I can sign and understand the study details.
- I am a candidate for surgery.
- I have estrogen-positive breast cancer.
- My HER2 test result is negative or low.
- I can take oral medication.
- I am willing to attend scheduled visits.
You may not be able to join if
- I cannot comply with taking hormone therapy.
- I cannot follow study procedures.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to determine how the duration of hormone blocking (endocrine) therapy given prior to surgery (called "neoadjuvant" treatment) affects breast cancer. The main questions the trial aims is answer are:
1. How breast cancer responds to endocrine therapy given prior to surgery?
2. To predict tumor pre-operative endocrine prognostic index (PEPI) score for subjects enro…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Be capable of understanding the investigational nature of the study and all pertinent aspects of the study
* Be capable of signing and providing written consent in accordance with institutional and federal guidelines
* Histologically or cytologically confirmed diagnosis of inv…
Contacts